Alan Brill, MD
Otolaryngology · Columbia, SCNPI 1033182399
Payments from drug & device makers
Across 50 payments — averaging $17.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optinose US, Inc.$348
- GSK$128
- AbbVie$85
- Sanofi$59
- Organogenesis Inc.$44
- Hikma Pharmaceuticals USA$42
- plus $155 from 7 others
What the payments were for
- Food & beverage$861100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Optinose US, Inc. | 22 | $348 |
| GSK | 7 | $128 |
| AbbVie | 4 | $85 |
| Sanofi | 2 | $59 |
| Organogenesis Inc. | 2 | $44 |
| Hikma Pharmaceuticals USA | 3 | $42 |
| Medtronic(2 entities) | 3 | $41 |
| Kerecis Limited | 2 | $32 |
| Stryker | 1 | $28 |
| Integra Lifesciences Corporation | 1 | $14 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
| Smith+Nephew | 1 | $13 |
| Johnson & Johnson | 1 | $12 |
How this compares
$861 in reported general payments places this provider in the 40th percentile of 180 otolaryngology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort | 73 | $4,970 |
| Fluticasone Propionate | 107 | $2,169 |
| Fluocinolone Acetonide Oil | 30 | $1,268 |
| Montelukast Sodium | 93 | $1,101 |
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 13 | $610 |
| Mupirocin | 69 | $493 |
| Azelastine Hcl | 12 | $474 |
| Methylprednisolone | 81 | $470 |
| Amoxicillin | 184 | $405 |
| Betamethasone Valerate | 27 | $403 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 61 | $300 |
| ValacyclovirValacyclovir Hcl | 18 | $286 |
| Omeprazole | 25 | $254 |
| Azithromycin | 75 | $189 |
| Meclizine Hcl | 39 | $105 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Columbia
- Shaun NguyenCharleston$1.3M
- Zachary SolerCharleston$834K
- Rodney SchlosserCharleston$643K
- Henry ButehornSpartanburg$340K
- Ted MeyerCharleston$327K
- Alexandra KejnerCharleston$244K
- John AnsleyOrangeburg$221K
- Eugene BrownCharleston$148K
- David NeskeyCharleston$139K
- Terrence DayCharleston$121K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.